“…An altered erythrocyte Ca ++ -ATPase activity has been linked to the development of neuropathy in diabetes (Jain & Lim, 2000). The decrease in Ca ++ -ATPase activity in type 2 diabetes may be due to altered membrane properties including functional and compositional changes (Shin et al, 2007;Bakan et al, 2006). A relationship has been reported between the blood glucose levels and erythrocyte membrane ATPases (Adamson et al, 1986).…”